Methods We searched PubMed for studies published before March 2025
In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more
Many California patients explore medically assisted weight loss after traditional approaches havent delivered the progress they hoped for
At TrimRx, we believe that understanding the difference between common adjustments and serious warning signs is the first step toward a safe and successful outcome, and you can take the free assessment quiz if you want to see whether a personalized program is a fit for you
If youre doing well (side effects are manageable), theyll instruct you to move to the next dose step